These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23017540)

  • 1. The prevalence of metabolic syndrome in drug-naïve bipolar II disorder patients before and after twelve week pharmacological intervention.
    Hung Chi M; Hua Chang H; Tzeng NS; Huang SY; Chou KR; Chun Tsai H; Kuang Yang Y; Lu RB; See Chen P
    J Affect Disord; 2013 Mar; 146(1):79-83. PubMed ID: 23017540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Acta Psychiatr Scand; 2015 Feb; 131(2):120-8. PubMed ID: 25131388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    PLoS One; 2013; 8(6):e66847. PubMed ID: 23826157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
    Kowatch RA; Scheffer RE; Monroe E; Delgado S; Altaye M; Lagory D
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):306-13. PubMed ID: 25978742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive function and risk for PCOS in women treated for bipolar disorder.
    Rasgon NL; Altshuler LL; Fairbanks L; Elman S; Bitran J; Labarca R; Saad M; Kupka R; Nolen WA; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich G; Grunze H; Walden J; Post R; Mintz J
    Bipolar Disord; 2005 Jun; 7(3):246-59. PubMed ID: 15898962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.
    Fiedorowicz JG; Palagummi NM; Forman-Hoffman VL; Miller DD; Haynes WG
    Ann Clin Psychiatry; 2008; 20(3):131-7. PubMed ID: 18633739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
    Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
    Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.
    Akiskal HS; Akiskal KK; Lancrenon S; Hantouche EG; Fraud JP; Gury C; Allilaire JF
    J Affect Disord; 2006 Dec; 96(3):197-205. PubMed ID: 16824616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan.
    Chang HH; Chou CH; Chen PS; Gean PW; Huang HC; Lin CY; Yang YK; Lu RB
    J Affect Disord; 2009 Sep; 117(1-2):124-9. PubMed ID: 19193445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
    Kemp DE; De Hert M; Rahman Z; Fyans P; Eudicone JM; Marler SV; Baker RA; Carlson BX
    J Affect Disord; 2013 May; 148(1):84-91. PubMed ID: 23261129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing new diagnostic criteria for hypomania.
    Benazzi F
    Ann Clin Psychiatry; 2007; 19(2):99-104. PubMed ID: 17612849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
    Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate.
    Chang HH; Chen PS; Cheng YW; Wang TY; Yang YK; Lu RB
    Int J Neuropsychopharmacol; 2018 Apr; 21(4):319-324. PubMed ID: 29618013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.
    Chang TT; Chen SL; Chang YH; Chen PS; Chu CH; Chen SH; Huang SY; Tzeng NS; Wang LJ; Wang TY; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB; Lee SY
    Medicine (Baltimore); 2016 Jun; 95(24):e3488. PubMed ID: 27310943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.
    Saloojee S; Burns JK; Motala AA
    Early Interv Psychiatry; 2018 Dec; 12(6):1137-1143. PubMed ID: 28402033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.